Tenpoint eyes presbyopia drug launch after FDA nod Tenpoint is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis Pharma, and LENZ Therapeutics.

#TenpointTherapeutics is set to join the #USmarket for drugs to treat #presbyopia, taking on rival therapies from #AbbVie, #OrasisPharma, and #LENZTherapeutics, after getting FDA approval for its #Yuvezzi product.